We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+35%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$3.72B
AUM Growth
+$1.3B
Cap. Flow
+$773M
Cap. Flow %
20.79%
Top 10 Hldgs %
33.57%
Holding
332
New
177
Increased
34
Reduced
21
Closed
82

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.38%
2 Technology 11.66%
3 Financials 7.64%
4 Communication Services 6.56%
5 Consumer Staples 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPENW
201
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$1.21M 0.03%
+333,333
New +$1.23M
VRT.WS
202
DELISTED
Vertiv Holdings Co Warrants, each whole warrant exercisable for one share of Class A Common Stock at
VRT.WS
$1.2M 0.03%
+300,000
New +$967K
IQ icon
203
iQIYI
IQ
$1.24B
$1.19M 0.03%
+51,178
New +$949K
GPRE icon
204
Green Plains
GPRE
$1.21B
$1.06M 0.03%
+103,919
New +$766K
SILK
205
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.05M 0.03%
+25,000
New +$960K
FUSE.U
206
DELISTED
Fusion Acquisition Corp. Units, each consisting of one share of Class A common stock, $0.0001 par va
FUSE.U
$1.02M 0.03%
+100,000
New +$1.02M
XLK icon
207
State Street Technology Select Sector SPDR ETF
XLK
$115B
$1M 0.03%
+19,200
New +$903K
RPRX icon
208
Royalty Pharma
RPRX
$26.2B
$971K 0.03%
+20,000
New +$990K
HTH icon
209
Hilltop Holdings
HTH
$2.26B
$923K 0.02%
+50,000
New +$859K
CLOVW
210
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$900K 0.02%
+300,000
New +$835K
RCUS icon
211
Arcus Biosciences
RCUS
$3.55B
$866K 0.02%
+35,000
New +$945K
AVDL
212
DELISTED
Avadel Pharmaceuticals
AVDL
$808K 0.02%
+100,000
New +$882K
MU icon
213
Micron Technology
MU
$988B
$772K 0.02%
14,992
-10,008
-40% -$472K
CCXX.WS
214
DELISTED
Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex
CCXX.WS
$750K 0.02%
+250,000
New +$459K
GHIVW
215
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
$675K 0.02%
+375,000
New +$549K
BYSI icon
216
BeyondSpring
BYSI
$46.5M
$671K 0.02%
44,485
+24,485
+122% +$374K
CTMX icon
217
CytomX Therapeutics
CTMX
$714M
$625K 0.02%
75,000
-25,000
-25% -$232K
BLUE
218
DELISTED
bluebird bio
BLUE
$610K 0.02%
+772
New +$582K
ARYBU
219
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$580K 0.02%
+50,000
New +$550K
RSI icon
220
Rush Street Interactive
RSI
$2.76B
$532K 0.01%
+53,000
New +$517K
NARI
221
DELISTED
Inari Medical, Inc. Common Stock
NARI
$484K 0.01%
+10,000
New +$478K
FVAC.WS
222
DELISTED
Fortress Value Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FVAC.WS
$470K 0.01%
+333,333
New +$505K
XERS icon
223
Xeris Biopharma Holdings
XERS
$1.45B
$466K 0.01%
175,000
IPOC.U
224
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
$451K 0.01%
+37,977
New +$406K
BOC icon
225
Boston Omaha
BOC
$425M
$400K 0.01%
+25,000
New +$417K

Similar funds

Moore Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Moore Capital Management held 332 positions worth $3.72B, up 54% from $2.42B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Moore Capital Management deployed $773M of net new capital in Q2 2020, opening 177 new positions and adding to 34 existing holdings. Its largest new stake was CyrusOne Inc Common Stock: 704,110 shares worth $51.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $52.3M trimmed.

  • Moore Capital Management's largest Q2 2020 buy was CyrusOne Inc Common Stock: 704,110 shares worth $51.2M.
  • Moore Capital Management added most to Alibaba in Q2 2020, an estimated $144M increase.
  • Moore Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $52.3M.
  • Moore Capital Management fully exited Vanguard Short-Term Corporate Bond ETF in Q2 2020, selling an estimated $267M.
  • Moore Capital Management's ten largest holdings make up 34% of its $3.72B portfolio in Q2 2020.
  • Moore Capital Management opened 177 new positions and closed 82 in Q2 2020.
  • Moore Capital Management's portfolio value rose 54% quarter-over-quarter to $3.72B.

Based on Moore Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.